Cantitate/Preț
Produs
Total produse
Vezi coșul
Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy de Emmanuel Donnadieu

Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy: Resistance to Targeted Anti-Cancer Therapeutics, cartea 9

Editat de Emmanuel Donnadieu
en Limba Engleză Hardback – 6 sep 2016
This volume focuses on recent advances in understanding T cells as key players in antitumor immune responses, and as a result T cell-based immunotherapy is starting to transform the treatment of advanced cancers. However, despite recent successes, many patients with cancer fail to respond to these treatments. Defective migration of T cells into and within tumors is considered as an important resistance mechanism to cancer immunotherapy.
The volume includes three sections. The first section covers general knowledge about T cell trafficking during a normal immune response but also during tumor development. The second section provides an in-depth description of the different obstacles that prevent T cells from migrating and contacting tumor cells. The third section explores therapeutic strategies to improve trafficking of T cells into tumors and, thus, to enhance the effectiveness of cancer immunotherapy.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 69060 lei  6-8 săpt.
  Springer International Publishing – 22 apr 2018 69060 lei  6-8 săpt.
Hardback (1) 69718 lei  6-8 săpt.
  Springer International Publishing – 6 sep 2016 69718 lei  6-8 săpt.

Din seria Resistance to Targeted Anti-Cancer Therapeutics

  • 5% Current Applications for Overcoming Resistance to Targeted Therapies
    Preț: 69754 lei
  • 5% Resistance to Proteasome Inhibitors in Cancer: Molecular Mechanisms and Strategies to Overcome Resistance
    Preț: 107543 lei
  • 5% Resistance to Tyrosine Kinase Inhibitors
    Preț: 106464 lei
  • 5% Resistance to Targeted Therapies Against Adult Brain Cancers
    Preț: 106870 lei
  • 5% Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy: Targeted Therapies to Reverse Resistance
    Preț: 106197 lei
  • 5% TRAIL, Fas Ligand, TNF and TLR3 in Cancer
    Preț: 107157 lei
  • 5% Resistance to Molecular Therapies for Hepatocellular Carcinoma
    Preț: 106248 lei
  • 5% Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways
    Preț: 106782 lei
  • 5% Resistance to Targeted Therapies in Breast Cancer
    Preț: 106464 lei
  • 5% Resistance of Targeted Therapies Excluding Antibodies for Lymphomas
    Preț: 81690 lei
  • 5% Resistance to Ibritumomab in Lymphoma
    Preț: 69542 lei
  • 5% Cancer Stem Cell Resistance to Targeted Therapy
    Preț: 69437 lei
  • 5% Resistance to Immunotherapeutic Antibodies in Cancer: Strategies to Overcome Resistance
    Preț: 106248 lei
  • 5% Resistance to Targeted Therapies in Lymphomas
    Preț: 69186 lei
  • 5% Resistance to Targeted Therapies in Multiple Myeloma
    Preț: 99519 lei
  • 5% Resistance to Targeted ABC Transporters in Cancer
    Preț: 70285 lei
  • 5% Resistance to Photodynamic Therapy in Cancer
    Preț: 70055 lei
  • 5% Resistance to Immunotoxins in Cancer Therapy
    Preț: 70055 lei
  • 5% Resistance of Cancer Cells to CTL-Mediated Immunotherapy
    Preț: 70586 lei
  • 5% Resistance to Aromatase Inhibitors in Breast Cancer
    Preț: 70250 lei

Preț: 69718 lei

Preț vechi: 73388 lei
-5% Nou

Puncte Express: 1046
Preț estimativ în valută:
13344€ • 13908$ • 11108£

Carte tipărită la comandă

Livrare economică 07-21 ianuarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783319422213
ISBN-10: 3319422219
Pagini: 250
Ilustrații: VIII, 199 p. 27 illus., 19 illus. in color.
Dimensiuni: 155 x 235 x 13 mm
Greutate: 0.47 kg
Ediția:1st ed. 2016
Editura: Springer International Publishing
Colecția Springer
Seria Resistance to Targeted Anti-Cancer Therapeutics

Locul publicării:Cham, Switzerland

Cuprins

Introduction.- Basic rules of T cell migration.- Regulation of anti-tumor T cell migration and function: contribution of real-time imaging.- 
Vascular normalization, T cell trafficking and anti-tumor immunity.- Disruption of anti-tumor T cell responses by cancer-associated fibroblasts.- Cancer-associated Tertiary Lymphoid Structures, from basic knowledge toward therapeutic target in clinic.- Homing Improvement: Boosting T Cell Trafficking for Cancer Immunotherapy.- Chemokines and T cell trafficking into tumors. Strategies to enhance recruitment of T cells into tumors.- Strategies to enhance migration and persistence of chimeric antigen receptor (CAR)-T cells into tumors.

Notă biografică

Emmanuel Donnadieu, Ph.D, is a researcher and team leader of the 'Dynamics of T cell Interactions' group at the Cochin Institute. His recent research include breakthroughs in newly developed methods for following the migration and activation patterns of lymphocytes and other immune cells within tumors.

Textul de pe ultima copertă

This volume focuses on recent advances in understanding T cells as key players in antitumor immune responses, and as a result T cell-based immunotherapy is starting to transform the treatment of advanced cancers. However, despite recent successes, many patients with cancer fail to respond to these treatments. Defective migration of T cells into and within tumors is considered as an important resistance mechanism to cancer immunotherapy.

The volume includes three sections. The first section covers general knowledge about T cell trafficking during a normal immune response but also during tumor development. The second section provides an in-depth description of the different obstacles that prevent T cells from migrating and contacting tumor cells. The third section explores therapeutic strategies to improve trafficking of T cells into tumors and, thus, to enhance the effectiveness of cancer immunotherapy.

Caracteristici

Gives the latest research on specific defects in T cell trafficking, which hinder the success of cancer immunotherapy Provides the basic priniciples to T cell migration during efficient immune responses Explores therapeutic interventions to promote T cell migration into tumors Includes supplementary material: sn.pub/extras